Michael Cintolo

Vice President of Investments and Chief Analyst,

Cabot Heritage Corporation

  • Chief Analyst of Cabot Growth Investor & Cabot Top Ten Trader
  • Uncovered Exceptional Growth Stocks
  • Helped to Create New Tools & Rules for Buying & Selling Stocks.

About Michael

During his more than ten years at Cabot, Michael Cintolo has uncovered exceptional growth stocks and helped to create new tools and rules for buying and selling stocks. Perhaps most notable was his development of the proprietary trend-following market timing system, Cabot Tides, which has helped Cabot place among the top investment newsletters numerous times. Cabot Growth Investor has been consistently recognized for outstanding performance by Hulbert Financial Digest and Timer Digest. It is one of Hulbert's top five newsletters for five-year risk-adjusted performance with a 13.2% annualized return as of June 30, 2011. It is also ranked among the Top Ten Newsletters by Timer Digest for long-term performance.

Michael's Articles

Even with mortgage rates on the rise, strong demand from first-time Millennial home buyers, coupled with the work-from-home trend, is expected to keep building product sales high this year, observes Mike Cintolo, editor of Cabot Top Ten Trader.
In this environment, boring is good, and Bristol-Myers Squibb (BMY) is a giant pharma outfit with an excellent history of reliable results, notes Mike Cintolo, editor of Cabot Top Ten Trader.
The coming summer is expected to see vacation travel rebound to its best levels since before the pandemic broke, suggests Mike Cintolo, growth stock specialist and editor of Cabot Top Ten Trader.
Precious metals have outshined equities so far this year, and when gold soars, the shares of companies that mine the metal tend to significantly outperform the bullion in percentage terms, observes Mike Cintolo, editor of Cabot Top Ten Trader.

Michael's Videos

Now, at mid-year, Mike Cintolo highlights some of the best performers and their current outlook on these Top Picks: Arista Networks.